5000th patient treated with protons for eye tumours

From the patient's perspective at the treatment station: The proton beam is directed through the hole in the shield onto the tumour in the eye. The brass shield is adjusted to the individual tumour size and protects the surrounding tissue.

From the patient's perspective at the treatment station: The proton beam is directed through the hole in the shield onto the tumour in the eye. The brass shield is adjusted to the individual tumour size and protects the surrounding tissue. © HZB/. S. Kodalle

The treatment centre for eye tumour therapy in Berlin-Wannsee

The treatment centre for eye tumour therapy in Berlin-Wannsee © HZB/ S. Kodalle

For more than 25 years, Charité – Universitätsmedizin Berlin and the Helmholtz-Zentrum Berlin (HZB) have been jointly offering proton radiation therapy for eye tumours. The HZB operates a proton accelerator in Berlin-Wannsee for this purpose, while Charité provides medical care for the patients. The 5000th patient was treated at the beginning of August.

The treatment room and proton accelerator are specially adapted to the requirements for optimal and highly precise treatment of tumours inside the eye and are unique in this combination. The largest group of tumours in the eye is the rare and malignant uveal melanoma, which, as the name suggests, develops in the uvea of the eye.

Proton therapy is used as an effective method of fighting tumours, often as an alternative to removing the eye, with the aim of preserving the eye and its function as much as possible. The protons can be directed very precisely at the tumour, sparing the surrounding healthy tissue. Compared to other radiation methods, proton therapy causes less damage to the cornea, lens, retina and optic nerve in many cases.

8 August 2025 was a special day: it was the day on which the 5000th patient completed their eye tumour treatment. This makes the Berlin experts one of the world's leading centres: together, the two institutions (Charité and HZB) have treated 10 percent of all eye tumours treated with protons worldwide. The cooperation with Charité – Universitätsmedizin Berlin also opens up prospects for the further development of proton therapy in order to carry out even more precise and effective treatments in the future – for the benefit of patients.

(sz)

  • Copy link

You might also be interested in

  • Synchrotron radiation sources: toolboxes for quantum technologies
    Science Highlight
    01.12.2025
    Synchrotron radiation sources: toolboxes for quantum technologies
    Synchrotron radiation sources generate highly brilliant light pulses, ranging from infrared to hard X-rays, which can be used to gain deep insights into complex materials. An international team has now published an overview on synchrotron methods for the further development of quantum materials and technologies in the journal Advanced Functional Materials: Using concrete examples, they show how these unique tools can help to unlock the potential of quantum technologies such as quantum computing, overcome production barriers and pave the way for future breakthroughs.
  • How carbonates influence CO2-to-fuel conversion
    Science Highlight
    25.11.2025
    How carbonates influence CO2-to-fuel conversion
    Researchers from the Helmholtz Zentrum Berlin (HZB) and the Fritz Haber Institute of the Max Planck Society (FHI) have uncovered how carbonate molecules affect the conversion of CO2 into valuable fuels on gold electrocatalysts. Their findings reveal key molecular mechanisms in CO2 electrocatalysis and hydrogen evolution, pointing to new strategies for improving energy efficiency and reaction selectivity.

  • Peat as a sustainable precursor for fuel cell catalyst materials
    Science Highlight
    25.11.2025
    Peat as a sustainable precursor for fuel cell catalyst materials
    Iron-nitrogen-carbon catalysts have the potential to replace the more expensive platinum catalysts currently used in fuel cells. This is shown by a study conducted by researchers from the Helmholtz-Zentrum Berlin (HZB), Physikalisch-Technische Bundesanstalt (PTB) and universities in Tartu and Tallinn, Estonia. At BESSY II, the team observed the formation of complex microstructures within various samples. They then analysed which structural parameters were particularly important for fostering the preferred electrochemical reactions. The raw material for such catalysts is well decomposed peat.